Skip to main content
Full access
Letter to the Editor
Published Online: 1 January 2000

Meige’s Syndrome Associated With Risperidone Therapy

Publication: American Journal of Psychiatry
To the Editor: Risperidone is an atypical antipsychotic that is effective for the positive, negative, and cognitive symptoms of schizophrenia (1). The incidence of extrapyramidal signs has been reported to be low during treatment with a dose of 6 mg/day. We report a case of Meige’s disease (24), an extrapyramidal syndrome that was secondary to risperidone treatment.
Mr. A was a 43-year-old, single Caucasian male who became psychiatrically ill at age 22 years and had since been taking various neuroleptics. From 1980 to 1996, he was prescribed thioridazine, 50 mg/day. More recently, his thioridazine therapy was changed to treatment with risperidone, 6 mg/day, as a result of an exacerbation of his symptoms. Mr. A then started blinking frequently. Sometime later, he noted episodic blepharospasms that either occurred spontaneously or were triggered by stress. As a result, he had to discontinue vision-dependent activities such as driving. More recently, he sought help for blepharospasms.
During an interview, Mr. A was noted to have intermittent blepharospasms that affected his vision. The more he tried to open his eyes, the more tightly his eyelids closed. He often struggled for about 3–5 minutes to open his eyes.
This patient had Meige’s disease that was secondary to his risperidone treatment. Because dopamine-2 blocking agents such as neuroleptics have been known to cause Meige’s disease (5), this finding is not surprising. In this case, tardive dystonia was ruled out because he had no other evidence of choreoathetotic movements elsewhere in his body. Spontaneous Meige’s disease was ruled out because of the absence of a family history of Parkinson’s disease, abnormal facial movements, and concomitant physical illnesses such as multiple sclerosis or autoimmune disorders. It is important to recognize this condition because the withdrawal of antipsychotic drugs may lead to a complete recovery from Meige’s disease.

References

1.
Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994; 151:825–835
2.
Meige H: Les convulsions de la face, une forme clinique de convulsion faciale, bilaterale et mediane. Rev Neurol (Paris) 1910; 20:437–443
3.
Faulstich ME, Carnicke CLM, Williamson DA: Blepharospasm and Meige’s syndrome: a review of diagnostic, etiologic and treatment approaches. J Psychosom Res 1985; 29:89–94
4.
Jankovic J, Ford J: Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983; 13:402–411
5.
Ananth J, Edelmuth E, Dargan B: Meige’s syndrome associated with neuroleptic treatment. Am J Psychiatry 1988; 145:513–515

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 149
PubMed: 10618045

History

Published online: 1 January 2000
Published in print: January 2000

Authors

Affiliations

SANDRA AQUINO, M.D.
Torrance, Calif.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share